Novo Nordisk Recalls 6 Lots of GlucaGen HypoKit

Novo Nordisk has recalled six batches of its GlucaGen HypoKit due to two customer complaints involving detached needles on the syringe with sterile water for injection. The product is indicated for treating severe hypoglycemia (low blood sugar) in patients with diabetes who are treated with insulin. “Untreated hypoglycemia can eventually lead to unconsciousness and seizures, which can prove fatal,” a recall notice says. “If the blood glucose levels are not quickly restored, continuing hypoglycemia can lead to a decline in brain glucose levels which manifests through a variety of symptoms including cognitive dysfunction, sweating, tremors, convulsion and eventually coma or death.”

Novo Nordisk says it conducted an investigation which showed that a small number (0.006%) of needles could be detached from the syringe in certain batches. Out of the 71,000 pens being recalled, four pens could be defective, it says.